CP and hepatocellular carcinoma: HCC with no extrahepatic spread/vascular invasion, CP A/B patient  - 0–3 nodules: EBRT as alternative  - 2–3 nodules, >3 cm: EBRT and SIRT as alternative  - ≥4 nodules: SIRT as alternative HCC with no extrahepatic spread/vascular invasion, CP C patient within transplant criteria - EBRT as bridging therapy HCC with no extrahepatic spread but with vascular invasion, CP A/B patient  - TACE in combination with EBRT or SIRT